Gunter von Minckwitz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Rom J; von Minckwitz G; Marmé F; Ataseven B; Kozian D; Sievert M; Schlehe B; Schuetz F; Scharf A; Kaufmann M; Sohn C; Schneeweiss A
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer.
von Minckwitz Gunter; Linder Mattea; Loibl Sibylle
The reawakening of bendamustine - also in breast cancer?
von Minckwitz Gunter; du Bois Andreas; Schmidt Marcus; Maass Nicolai; Cufer Tanja; de Jongh Felix E; Maartense Eduard; Zielinski Christoph; Kaufmann Manfred; Bauer Wolfgang; Baumann Klaus H; Clemens Michael R; Duerr Ralph; Uleer Christoph; Andersson Michael; Stein Robert C; Nekljudova Valentina; Loibl Sibylle
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gunter von Minckwitz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rom J; von Minckwitz G; Marmé F; Ataseven B; Kozian D; Sievert M; Schlehe B; Schuetz F; Scharf A; Kaufmann M; Sohn C; Schneeweiss A
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(11):1829-35.
2009: von Minckwitz Gunter; Linder Mattea; Loibl Sibylle
The reawakening of bendamustine - also in breast cancer?
Onkologie 2009;32(8-9):462-3.
2009: von Minckwitz Gunter; du Bois Andreas; Schmidt Marcus; Maass Nicolai; Cufer Tanja; de Jongh Felix E; Maartense Eduard; Zielinski Christoph; Kaufmann Manfred; Bauer Wolfgang; Baumann Klaus H; Clemens Michael R; Duerr Ralph; Uleer Christoph; Andersson Michael; Stein Robert C; Nekljudova Valentina; Loibl Sibylle
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1999-2006.
2009: Loibl Sibylle; Murmann Caroline; Schwedler Katrin; Warm Mathias; Müller Lothar; Heinrich Georg; Nekljudova Valentina; von Minckwitz Gunter
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Cancer chemotherapy and pharmacology 2009;63(5):953-8.
2009: von Minckwitz G; Schwenkglenks M; Skacel T; Lyman G H; Pousa A Lopez; Bacon P; Easton V; Aapro M S
Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis.
European journal of cancer (Oxford, England : 1990) 2009;45(4):608-17.
2009: Baker Jackie; Ajani Jaffer; Scotté Florian; Winther Dorte; Martin Miguel; Aapro Matti S; von Minckwitz Gunter
Docetaxel-related side effects and their management.
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2009;13(1):49-59.
2009: Schmidt M; Victor A; Bratzel D; Boehm D; Cotarelo C; Lebrecht A; Siggelkow W; Hengstler J G; Elsässer A; Gehrmann M; Lehr H-A; Koelbl H; von Minckwitz G; Harbeck N; Thomssen C
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(2):258-64.
2009: Untch Michael; von Minckwitz Gunter
Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.
Breast cancer research : BCR 2009;11(2):203.
2008: Ruckhäberle Eugen; Rody Achim; Engels Knut; Gaetje Regine; von Minckwitz Gunter; Schiffmann Susanne; Grösch Sabine; Geisslinger Gerd; Holtrich Uwe; Karn Thomas; Kaufmann Manfred
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
Breast cancer research and treatment 2008;112(1):41-52.
2008: Rom J; von Minckwitz G; Eiermann W; Sievert M; Schlehe B; Marmé F; Schuetz F; Scharf A; Eichbaum M; Sinn H-P; Kaufmann M; Sohn C; Schneeweiss A
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1698-705.
2008: Baker Jackie; Ajani Jaffer; Scotté Florian; Winther Dorte; Martin Miguel; Aapro Matti S; von Minckwitz Gunter
Docetaxel-related side effects and their management.
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2008;12(3):253-68.
2008: von Minckwitz Gunter; Kümmel Sherko; Vogel Petra; Hanusch Claus; Eidtmann Holger; Hilfrich Jörn; Gerber Bernd; Huober Jens; Costa Serban Dan; Jackisch Christian; Loibl Sibylle; Mehta Keyur; Kaufmann Manfred;
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
Journal of the National Cancer Institute 2008;100(8):542-51.
2008: von Minckwitz Gunter; Kümmel Sherko; Vogel Petra; Hanusch Claus; Eidtmann Holger; Hilfrich Jörn; Gerber Bernd; Huober Jens; Costa Serban Dan; Jackisch Christian; Loibl Sibylle; Mehta Keyur; Kaufmann Manfred;
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.
Journal of the National Cancer Institute 2008;100(8):552-62.
2008: Bundred Nigel J; Campbell Ian D; Davidson Neville; DeBoer Richard H; Eidtmann Holger; Monnier Alain; Neven Patrick; von Minckwitz Gunter; Miller Joel C; Schenk Nora L; Coleman Robert E
Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
Cancer 2008;112(5):1001-10.
2008: Gralow Julie R; Burstein Harold J; Wood William; Hortobagyi Gabriel N; Gianni Luca; von Minckwitz Gunter; Buzdar Aman U; Smith Ian E; Symmans William F; Singh Baljit; Winer Eric P
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):814-9.
2008: von Minckwitz G; Kümmel S; du Bois A; Eiermann W; Eidtmann H; Gerber B; Hilfrich J; Huober J; Costa S D; Jackisch C; Grasshoff S-T; Vescia S; Skacel T; Loibl S; Mehta K M; Kaufmann M;
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):292-8.
2008: Loibl Sibylle; von Minckwitz Gunter; Harbeck Nadia; Janni Wolfgang; Elling Dirk; Kaufmann Manfred; Eggemann Holm; Nekljudova Valentina; Sommer Harald; Kiechle Marion; Kümmel Sherko
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.
Breast cancer research : BCR 2008;10(5):R77.
2008: von Minckwitz Gunter
[High-risk situation - which is the best chemotherapy?]
Gynäkologisch-geburtshilfliche Rundschau 2008;48(3):118-29.
2008: von Minckwitz Gunter; Sinn Hans-Peter; Raab Günter; Loibl Sibylle; Blohmer Jens-Uwe; Eidtmann Holger; Hilfrich Jörn; Merkle Elisabeth; Jackisch Christian; Costa Serban D; Caputo Angelika; Kaufmann Manfred;
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.
Breast cancer research : BCR 2008;10(2):R30.
2008: von Minckwitz Gunter
Breakthrough for neoadjuvant chemotherapy.
Breast cancer (Tokyo, Japan) 2008;15(1):27-30.
2007: Kaufmann M; von Minckwitz G; Bear H D; Buzdar A; McGale P; Bonnefoi H; Colleoni M; Denkert C; Eiermann W; Jackesz R; Makris A; Miller W; Pierga J-Y; Semiglazov V; Schneeweiss A; Souchon R; Stearns V; Untch M; Loibl S
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1927-34.
2007: Kaufmann Manfred; Graf Erika; Jonat Walter; Eiermann Wolfgang; Vescia Sabine; Geberth Matthias; Conrad Bettina; Gademann Günther; Albert Ute-Susann; Loibl Sibylle; von Minckwitz Gunter; Schumacher Martin;
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93.
European journal of cancer (Oxford, England : 1990) 2007;43(16):2351-8.
2007: Kaufmann Manfred; Jonat Walter; Hilfrich Jörn; Eidtmann Holger; Gademann Günther; Zuna Ivan; von Minckwitz Gunter
Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2664-70.
2007: Müller Christine; Caputo Angelika; Schumacher Martin; Raab Günter; Schütte Martin; Hilfrich Jörn; Kaufmann Manfred; von Minckwitz Gunter
Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer: further results from a randomised controlled trial.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1654-61.
2007: Crivellari Diana; Aapro Matti; Leonard Robert; von Minckwitz Gunter; Brain Etienne; Goldhirsch Aron; Veronesi Andrea; Muss Hyman
Breast cancer in the elderly.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(14):1882-90.
2007: Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta K M; Kaufmann M
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):689-93.
2007: von Minckwitz Gunter
Docetaxel/anthracycline combinations for breast cancer treatment.
Expert opinion on pharmacotherapy 2007;8(4):485-95.
2007: Oskay-Ozcelik G; Lehmacher W; Könsgen D; Christ H; Kaufmann M; Lichtenegger W; Bamberg M; Wallwiener D; Overkamp F; Diedrich K; von Minckwitz G; Höffken K; Seeber S; Mirz R; Sehouli J
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):479-84.
2007: Rody Achim; Holtrich Uwe; Gaetje Regine; Gehrmann Mathias; Engels Knut; von Minckwitz Gunter; Loibl Sibylle; Diallo-Danebrock Raihanatou; Ruckhäberle Eugen; Metzler Dirk; Ahr Andre; Solbach Christine; Karn Thomas; Kaufmann Manfred
Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1115-22.
2007: Rody A; Karn T; Gätje R; Ahr A; Solbach C; Kourtis K; Munnes M; Loibl S; Kissler S; Ruckhäberle E; Holtrich U; von Minckwitz G; Kaufmann M
Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response.
Breast (Edinburgh, Scotland) 2007;16(1):86-93.
2007: Fasching Peter A; von Minckwitz Gunter; Fischer Thorsten; Kaufmann Manfred; Schultz-Zehden Beate; Beck Heike; Lux Michael P; Jacobs Volker; Meden Harald; Kiechle Marion; Beckmann Matthias W; Paepke Stefan
The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs.
Breast cancer research and treatment 2007;101(1):95-104.
2006: von Minckwitz Gunter;
Evidence-based treatment of metastatic breast cancer - 2006 recommendations by the AGO Breast Commission.
European journal of cancer (Oxford, England : 1990) 2006;42(17):2897-908.
2006: Loibl Sibylle; von Minckwitz Gunter; Raab Günther; Blohmer Jens-Uwe; Dan Costa Serban; Gerber Bernd; Eidtmann Holger; Petrich Simone; Hilfrich Jörn; Jackisch Christian; du Bois Andreas; Kaufmann Manfred
Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.
Annals of surgical oncology 2006;13(11):1434-42.
2006: von Minckwitz Gunter; Graf Erika; Geberth Matthias; Eiermann Wolfgang; Jonat Walter; Conrad Bettina; Brunnert Klaus; Gerber Bernd; Vescia Sabine; Wollert Jörg; Kaufmann Manfred
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
European journal of cancer (Oxford, England : 1990) 2006;42(12):1780-8.
2006: Al-Batran S-E; Bischoff J; von Minckwitz G; Atmaca A; Kleeberg U; Meuthen I; Morack G; Lerbs W; Hecker D; Sehouli J; Knuth A; Jager E
The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial.
British journal of cancer 2006;94(11):1615-20.
2006: Kaufmann Manfred; Hortobagyi Gabriel N; Goldhirsch Aron; Scholl Suzy; Makris Andreas; Valagussa Pinuccia; Blohmer Jens-Uwe; Eiermann Wolfgang; Jackesz Raimund; Jonat Walter; Lebeau Annette; Loibl Sibylle; Miller William; Seeber Sigfried; Semiglazov Vladimir; Smith Roy; Souchon Rainer; Stearns Vered; Untch Michael; von Minckwitz Gunter
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
2006: Loibl Sibylle; Kaufmann Manfred; Maataoui Vidya; Mehta Keyur M; Hofmann Katharina; Petrich Simone; von Minckwitz Gunter
Darbepoetin alfa as primary prophylaxis of anemia in patients with breast cancer treated preoperatively with docetaxel/doxorubicin/cyclophosphamide.
Supportive cancer therapy 2006;3(2):103-9.
2006: Loibl Sibylle; von Minckwitz Gunter; Gwyn Karin; Ellis Paul; Blohmer Jens U; Schlegelberger Brigitte; Keller Monika; Harder Sebastian; Theriault Richard L; Crivellari Diana; Klingebiel Thomas; Louwen Frank; Kaufmann Manfred
Breast carcinoma during pregnancy. International recommendations from an expert meeting.
Cancer 2006;106(2):237-46.
2006: Al-Batran Salah-Eddin; Meerpohl Hans-Gerd; von Minckwitz Gunter; Atmaca Akin; Kleeberg Ulrich; Harbeck Nadia; Lerbs Werner; Hecker Detlef; Sehouli Jalid; Knuth Alexander; Jager Elke
Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer.
Oncology 2006;70(2):141-6.
2006: Loibl Sibylle; Bratengeier Jutta; Farines Vincent; von Minckwitz Gunter; Spänkuch Birgit; Schini-Kerth Valérie; Nepveu Françoise; Strebhardt Klaus; Kaufmann Manfred
Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 - estrogen has an influence on e-NOS, but not on i-NOS.
Pathology, research and practice 2006;202(1):1-7.
2005: Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
Endocrine-related cancer 2005;12(4):903-16.
2005: Pöhls Uwe G; Fasching Peter A; Beck Heike; Kaufmann Manfred; Kiechle Marion; von Minckwitz Gunther; Paepke Stefan; Schultz-Zehden Beate; Schwarz-Boeger Ulrike; Beckmann Matthias W
Demographic and psychosocial factors associated with risk perception for breast cancer.
Oncology reports 2005;14(6):1605-13.
2005: Kaufmann Manfred; von Minckwitz Gunter; Rody Achim
Preoperative (neoadjuvant) systemic treatment of breast cancer.
Breast (Edinburgh, Scotland) 2005;14(6):576-81.
2005: Kaufmann Manfred; Graf Erika; Jonat Walter; Eiermann Wolfgang; Geberth Matthias; Albert Ute-Susann; Gademann Günther; Conrad Bettina; Stahl Karin; von Minckwitz Gunter; Schumacher Martin;
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7842-8.
2005: von Minckwitz G; Chernozemsky I; Sirakova L; Chilingirov P; Souchon R; Marschner N; Kleeberg U; Tsekov C; Fritze D; Thomssen C; Stuart N; Vermorken J B; Loibl S; Merkle Kh; Kaufmann M
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC.
Anti-cancer drugs 2005;16(8):871-7.
2005: Rody Achim; Loibl Sibylle; von Minckwitz Gunter; Kaufmann Manfred
Use of goserelin in the treatment of breast cancer.
Expert review of anticancer therapy 2005;5(4):591-604.
2005: Kaufmann M; Jonat W; Eiermann W; Costa S; Hilfrich J; Jänicke F; Beckmann M W; Wallwiener D; Gerber B; Rody A; Schneeweiss A; Nitz U; Köhler U; von Minckwitz G
[Systemic therapy of operable carcinoma of the breast]
Zentralblatt für Gynäkologie 2005;127(4):207-12.
2005: Loibl S; Strank C; von Minckwitz G; Sinn H-P; Buck A; Solbach C; Strebhardt K; Kaufmann M
Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer.
Breast (Edinburgh, Scotland) 2005;14(3):230-5.
2005: von Minckwitz Gunter; Raab Günter; Caputo Angelika; Schütte Martin; Hilfrich Jörn; Blohmer Jens U; Gerber Bernd; Costa Serban D; Merkle Elisabeth; Eidtmann Holger; Lampe Dieter; Jackisch Christian; du Bois Andreas; Kaufmann Manfred
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2676-85.
2005: von Minckwitz Gunter; Jonat Walter; Fasching Peter; du Bois Andreas; Kleeberg Ulrich; Lück Hans-Joachim; Kettner Erika; Hilfrich Jörn; Eiermann Wolfgang; Torode Julie; Schneeweiss Andreas
A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer.
Breast cancer research and treatment 2005;89(2):165-72.
2005: Loibl Sibylle; Buck Angela; Strank Cornelia; von Minckwitz Gunter; Roller Marc; Sinn Hans-Peter; Schini-Kerth Valerie; Solbach Christine; Strebhardt Klaus; Kaufmann Manfred
The role of early expression of inducible nitric oxide synthase in human breast cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(2):265-71.
2005: von Minckwitz G; Blohmer J-U; Raab G; Löhr A; Gerber B; Heinrich G; Eidtmann H; Kaufmann M; Hilfrich J; Jackisch C; Zuna I; Costa S D;
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(1):56-63.
2005: von Minckwitz Gunter; Harder Sebastian; Hövelmann Sascha; Jäger Elke; Al-Batran Salah-Eddin; Loibl Sibylle; Atmaca Akin; Cimpoiasu Christian; Neumann Antje; Abera Aklil; Knuth Alexander; Kaufmann Manfred; Jäger Dirk; Maurer Alexander B; Wels Winfried S
Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas.
Breast cancer research : BCR 2005;7(5):R617-26.
2004: Keller Alan M; Mennel Robert G; Georgoulias Vassilis A; Nabholtz Jean-Marc; Erazo Aura; Lluch Anna; Vogel Charles L; Kaufmann Manfred; von Minckwitz Gunther; Henderson I Craig; Mellars Lillian; Alland Leila; Tendler Craig
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3893-901.
2004: Di Leo A; Chan S; Paesmans M; Friedrichs K; Pinter T; Cocquyt V; Murray E; Bodrogi I; Walpole E; Lesperance B; Korec S; Crown J; Simmonds P; Von Minckwitz G; Leroy J Y; Durbecq V; Isola J; Aapro M; Piccart M J; Larsimont D
HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.
Breast cancer research and treatment 2004;86(3):197-206.
2004: Konecny Gottfried E; Thomssen Christoph; Lück Hans Joachim; Untch Michael; Wang He-Jing; Kuhn Walter; Eidtmann Holger; du Bois Andreas; Olbricht Sigrid; Steinfeld Dieter; Möbus Volker; von Minckwitz Gunter; Dandekar Suganda; Ramos Lillian; Pauletti Giovanni; Pegram Mark D; Jänicke Fritz; Slamon Dennis J
Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer.
Journal of the National Cancer Institute 2004;96(15):1141-51.
2004: Loibl S; von Minckwitz G; Schwedler K; Schmidt K A; Höper D; Kaufmann M; Costa S D
Mitomycin C, 5-fluorouracil and folinic acid (Mi-Fu-Fo) as salvage chemotherapy in breast cancer patients with liver metastases and impaired hepatic function: a phase II study.
Anti-cancer drugs 2004;15(7):719-24.
2004: Müller Volkmar; Witzel Isabell; Lück Hans Joachim; Köhler Günter; von Minckwitz Gunther; Möbus Volker; Sattler Daniel; Wilczak Waldemar; Löning Thomas; Jänicke Fritz; Pantel Klaus; Thomssen Christoph
Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.
Breast cancer research and treatment 2004;86(1):9-18.
2004: Schneeweiss Andreas; Kolay Sema; Aulmann Sebastian; Von Minckwitz Gunter; Torode Julie; Koehler Maria; Bastert Gunther
Induction of remission in a patient with metastatic breast cancer refractory to trastuzumab and chemotherapy following treatment with gefitinib ('Iressa', ZD1839).
Anti-cancer drugs 2004;15(3):235-8.
2003: Azemar Marc; Djahansouzi Sirus; Jäger Elke; Solbach Christine; Schmidt Mathias; Maurer Alexander B; Mross Klaus; Unger Clemens; von Minckwitz Gunter; Dall Peter; Groner Bernd; Wels Winfried S
Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2.
Breast cancer research and treatment 2003;82(3):155-64.
2003: Thuss-Patience Peter C; von Minckwitz Gunter; Kretzschmar Albrecht; Loibl Sibylle; Schaller Gerhard; Dörken Bernd; Reichardt Peter
Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.
Anti-cancer drugs 2003;14(7):549-53.
2003: Reichardt P; Von Minckwitz G; Thuss-Patience P C; Jonat W; Kölbl H; Jänicke F; Kieback D G; Kuhn W; Schindler A E; Mohrmann S; Kaufmann M; Lück H J
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1227-33.
2003: Kaufmann Manfred; von Minckwitz Gunter; Smith Roy; Valero Vicente; Gianni Luca; Eiermann Wolfgang; Howell Anthony; Costa Serban Dan; Beuzeboc Philippe; Untch Michael; Blohmer Jens-Uwe; Sinn Hans-Peter; Sittek Rolf; Souchon Rainer; Tulusan Augustinos H; Volm Tanja; Senn Hans-Jörg
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2600-8.
2003: Diebold T; Jacobi V; Krapfl E; von Minckwitz G; Solbach C; Ballenberger S; Hochmuth K; Balzer J O; Fellbaum M; Kaufmann M; Vogl T J
[The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2003;175(4):489-94.
2002: Crown John; Diéras Véronique; Kaufmann Manfred; von Minckwitz Gunter; Kaye Stan; Leonard Robert; Marty Michel; Misset Jean-Louis; Osterwalder Bruno; Piccart Martine
Chemotherapy for metastatic breast cancer-report of a European expert panel.
The lancet oncology 2002;3(12):719-27.
2002: von Minckwitz G; Loibl S; Brunnert K; Kreienberg R; Melchert F; Mösch R; Neises M; Schermann J; Seufert R; Stiglmayer R; Stosiek U; Kaufmann M
Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial.
European journal of cancer (Oxford, England : 1990) 2002;38(17):2265-71.
2002: Jackisch Christian; von Minckwitz Gunter; Eidtmann Holger; Costa Serban Dan; Raab Günther; Blohmer Jens Uwe; Schütte Martin; Gerber Bernd; Merkle Elisabeth; Gademann Günther; Lampe Dieter; Hilfrich Jörn; Tulusan Augustinus-Harjanto; Caputo Angelika; Kaufmann Manfred
Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.
Clinical breast cancer 2002;3(4):276-80.
2002: Loibl Sibylle; von Minckwitz Gunter; Weber Sonja; Sinn Hans-Peter; Schini-Kerth Valérie B; Lobysheva Irina; Nepveu Françoise; Wolf Georg; Strebhardt Klaus; Kaufmann Manfred
Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.
Cancer 2002;95(6):1191-8.
2002: Von Minckwitz G; Brunnert K; Costa S D; Friedrichs K; Jackisch Ch; Gerber B; Harbeck N; Junkermann H; Möbus V; Nitz U; Schaller G; Scharl A; Thomssen Ch; Untch M;
[Evidence-based recommendations on primary treatment of carcinomas of the breast]
Zentralblatt für Gynäkologie 2002;124(5):293-303.
2002: Von Minckwitz G; Costa S D; Brunnert K; Dall P; Nitz U; Diel I; Fersis N; Friedrich M; Friedrichs K; Thomssen Ch; Gerber B; Göhring U-J; Harbeck N; Hanf V; Schaller G; Scharl A; Schmutzler R; Simon W E; Untch M;
[Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast]
Zentralblatt für Gynäkologie 2002;124(5):284-92.
2002: Spänkuch-Schmitt Birgit; Wolf Georg; Solbach Christine; Loibl Sibylle; Knecht Rainald; Stegmüller Manfred; von Minckwitz Gunter; Kaufmann Manfred; Strebhardt Klaus
Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
Oncogene 2002;21(20):3162-71.
2002: Costa S D; von Minckwitz G; Wernicke K; Kaufmann M
[New aspects by the therapy of ovarian cancer--What changes after the ASCO-Meeting 2001]
Zentralblatt für Gynäkologie 2002;124(2):96-103.
2002: Miles David; von Minckwitz Gunter; Seidman Andrew D
Combination versus sequential single-agent therapy in metastatic breast cancer.
The oncologist 2002;7 Suppl 6():13-9.
2001: von Minckwitz G; Raab G; Schütte M; Hilfrich J; Blohmer J U; Gerber B; Costa S D; Merkle E; Eidtmann H; Lampe D; Jackisch C; du Bois A; Tulusan A H; Gademann G; Sinn H P; Caputo A; Graf E; Kaufmann M
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]
Zentralblatt für Gynäkologie 2001;123(9):497-504.
2001: von Minckwitz G; Costa S D; Raab G; Blohmer J U; Eidtmann H; Hilfrich J; Merkle E; Jackisch C; Gademann G; Tulusan A H; Eiermann W; Graf E; Kaufmann M;
Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3506-15.
1999: Ahr A; Scharl A; Müller M; von Minckwitz G; Gätje R; Pantel K; Kaufmann M
Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11.
International journal of cancer. Journal international du cancer 1999;84(5):502-5.
1999: Ludwig R; Kretschmer M; Caspar G; Bojunga J; Oldenburg A; Schumm-Draeger P; Stegmüller M; von Minckwitz G; Usadel K H; Kusterer K
In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis.
Immunology 1999;98(1):111-5.
1999: Chan S; Friedrichs K; Noel D; Pintér T; Van Belle S; Vorobiof D; Duarte R; Gil Gil M; Bodrogi I; Murray E; Yelle L; von Minckwitz G; Korec S; Simmonds P; Buzzi F; González Mancha R; Richardson G; Walpole E; Ronzoni M; Murawsky M; Alakl M; Riva A; Crown J;
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2341-54.
1999: von Minckwitz G; Costa S D; Eiermann W; Blohmer J U; Tulusan A H; Jackisch C; Kaufmann M
Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):1999-2005.
1999: von Minckwitz G; Bauknecht T; Visseren-Grul C M; Neijt J P
Phase II study of gemcitabine in ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(7):853-5.
1999: Costa S D; von Minckwitz G; Raab G; Blohmer J U; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
Seminars in oncology 1999;26(3 Suppl 9):24-31.
1999: Kusterer K; Ludwig R; Hochschulz P; Stegmüller M; Bojunga J; von Minckwitz G
Macrophage and lymphocyte homing in experimental diabetes.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107 Suppl 3():S102-7.
1998: von Minckwitz G; Costa S D; Blohmer J; Eiermann W; Jakisch C; Tulusan A H; Kaufmann M
[Preoperative chemotherapy of breast carcinoma]
Zentralblatt für Chirurgie 1998;123 Suppl 5():138-41.
1998: von Minckwitz G; Kaufmann M
New endocrine approaches in the treatment of breast cancer.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1998;52(3):122-32.
1997: von Minckwitz G; Costa S D
[Docetaxel (taxotere) for therapy of breast carcinoma. Highest effectiveness with moderate side effects]
Medizinische Klinik (Munich, Germany : 1983) 1997;92 Suppl 4():4-9.
1997: Costa S D; von Minckwitz G; Gauwerky J F; Kaufmann M; Diel I J
Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):3023-4.
1997: Kaufmann M; von Minckwitz G
Gemcitabine in ovarian cancer: an overview of safety and efficacy.
European journal of cancer (Oxford, England : 1990) 1997;33 Suppl 1():S31-3.
1996: Diel I J; Kaufmann M; Costa S D; Holle R; von Minckwitz G; Solomayer E F; Kaul S; Bastert G
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Journal of the National Cancer Institute 1996;88(22):1652-8.
1995: Kaufmann M; Heider K H; Sinn H P; von Minckwitz G; Ponta H; Herrlich P
CD44 isoforms in prognosis of breast cancer.
Lancet 1995;346(8973):502.
1995: Kaufmann M; Heider K H; Sinn H P; von Minckwitz G; Ponta H; Herrlich P
CD44 variant exon epitopes in primary breast cancer and length of survival.
Lancet 1995;345(8950):615-9.
1995: Sinn H P; Heider K H; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Breast cancer research and treatment 1995;36(3):307-313.
1994: Dall P; Heider K H; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
Cancer research 1994;54(13):3337-41.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Gunter von Minckwitz

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Gunter von Minckwitz (preview)

All Publications